Dibucaine induces autophagic flux and reduces Ser129-phosphorylated α-synuclein in induced pluripotent stem cell–derived neurons with SNCA duplication
7 affiliations
- 1Department of Neurology, Juntendo University Faculty of Medicine
- 2Sumitomo Pharma Co., Ltd.
- 3Center for Genomic and Regenerative Medicine, Juntendo University Graduate School of Medicine
- 4Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine
- 5Division for Development of Autophagy Modulating Drugs, Juntendo University Faculty of Medicine
- 6Department of Neurology, Institute of Medicine, University of Tsukuba
- 7Neurodegenerative Disorders Collaboration Laboratory, RIKEN Center for Brain Science
Abstract
The accumulation of α-synuclein (α-syn) in the form of Lewy bodies and Lewy neurites is a neuropathological hallmark of Parkinson’s disease (PD) and is closely associated with disease progression. Targeting the autophagy pathway to enhance the clearance of α-syn aggregates therefore represents a promising therapeutic strategy. In the present study, we conducted high-throughput screening using rat embryonic primary neurons, followed by validation of the identified compounds in human induced pluripotent stem cell (iPSC)-derived neurons. We identified dibucaine, a local anesthetic, as a compound that induced autophagic flux in neuronal models. In human iPSC-derived dopaminergic neurons from a patient with PD carrying an SNCA duplication, dibucaine reduced cellular levels of Ser129-phosphorylated α-synuclein (pS129 α-syn). In SH-SY5Y cells, dibucaine increased 5’-AMP-activated protein kinase (AMPK) Thr172 phosphorylation. LY364947 partially attenuated dibucaine-induced LC3-II accumulation in the iPSC-derived neurons through an unidentified mechanism. Although the requirement for AMPK and the mechanism underlying the reduction in pS129 α-syn remain unresolved, our findings show that dibucaine induces autophagic flux and reduces pS129 α-syn levels in disease-relevant human neurons.
Related
- Serine-65 phosphorylated ubiquitin associates with soluble tau and seeding activity in Alzheimer’s disease
- Amyloid-Independent Elevation of Plasma phosphorylated tau-217 Tracks Neurodegenerative Risk in Tuberous Sclerosis Complex: Implications for mTOR-Targeted Intervention
- Gastric duplication cyst mimicking an adrenal-region cyst: a diagnostic challenge
- Unclear source of gastrointestinal bleeding: Utilizing small bowel capsule to detect an enteric duplication cyst, a case report
- Design, fabrication and molecular dynamics simulations of luteolin pickering emulsion using phosphorylated and succinylated lactoferrin nanocomplex
BibTeX
@article{kitagawa2026dibucaine,
title = {{Dibucaine induces autophagic flux and reduces Ser129-phosphorylated α-synuclein in induced pluripotent stem cell–derived neurons with SNCA duplication}},
author = {Mitsuhiro Kitagawa and Kengo Miyamoto and Kozo Yoshida and Kei-Ichi Ishikawa and Yukiko Sasazawa and Wado Akamatsu and Shinji Saiki and Taku Hatano and Masaya Imoto and Hidetaka Nagata and Nobutaka Hattori},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1891393},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1891393/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Dibucaine induces autophagic flux and reduces Ser129-phosphorylated α-synuclein in induced pluripotent stem cell–derived neurons with SNCA duplication
AU - Mitsuhiro Kitagawa
AU - Kengo Miyamoto
AU - Kozo Yoshida
AU - Kei-Ichi Ishikawa
AU - Yukiko Sasazawa
AU - Wado Akamatsu
AU - Shinji Saiki
AU - Taku Hatano
AU - Masaya Imoto
AU - Hidetaka Nagata
AU - Nobutaka Hattori
PY - 2026
DA - 2026/10/08
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1891393
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1891393/full
AB - The accumulation of α-synuclein (α-syn) in the form of Lewy bodies and Lewy neurites is a neuropathological hallmark of Parkinson’s disease (PD) and is closely associated with disease progression. Targeting the autophagy pathway to enhance the clearance of α-syn aggregates therefore represents a promising therapeutic strategy. In the present study, we conducted high-throughput screening using rat embryonic primary neurons, followed by validation of the identified compounds in human induced pluripotent stem cell (iPSC)-derived neurons. We identified dibucaine, a local anesthetic, as a compound that induced autophagic flux in neuronal models. In human iPSC-derived dopaminergic neurons from a patient with PD carrying an SNCA duplication, dibucaine reduced cellular levels of Ser129-phosphorylated α-synuclein (pS129 α-syn). In SH-SY5Y cells, dibucaine increased 5’-AMP-activated protein kinase (AMPK) Thr172 phosphorylation. LY364947 partially attenuated dibucaine-induced LC3-II accumulation in the iPSC-derived neurons through an unidentified mechanism. Although the requirement for AMPK and the mechanism underlying the reduction in pS129 α-syn remain unresolved, our findings show that dibucaine induces autophagic flux and reduces pS129 α-syn levels in disease-relevant human neurons.
SN - 1664-2295
ER -